Genelux Corporation (GNLX)
(Delayed Data from NSDQ)
$3.83 USD
-0.19 (-4.73%)
Updated May 10, 2024 04:00 PM ET
After-Market: $3.83 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Price, Consensus and EPS Surprise
GNLX 3.83 -0.19(-4.73%)
Will GNLX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for GNLX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GNLX
Down -48.37% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround
Down -45.44% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround
GNLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging -26.21% in 4 Weeks, Here's Why the Trend Might Reverse for Genelux Corporation (GNLX)
All You Need to Know About Genelux Corporation (GNLX) Rating Upgrade to Buy
IPO Round Up of First Half of 2023
Other News for GNLX
Buy Rating Affirmed for Genelux Corp on Strong Trial Progress and Solid Financials
Analysts’ Top Healthcare Picks: Caribou Biosciences (CRBU), Lineage Therap (LCTX)
Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates
GNLX Stock Earnings: Genelux Misses EPS for Q1 2024
Genelux Corp Unveils Strategic Corporate Outlook Presentation